This new service, offered by the analytical testing service of the clinical research business, ensures biopharmaceutical products are free of contaminants, helping customers deliver safe medicines for...
Read more
The new immunotherapy is based on the so-called STAb cells. It has yet to pass clinical trials and therefore it will be at least two years before it reaches the patients.
Read more
An international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this cancer after CAR T-cell therapy.
Read more
Investigadores del St. Jude Children’s Research Hospital han mejorado la inmunoterapia con células T receptoras de antígenos quiméricos (CAR) para la leucemia mieloide aguda, demostrando una mayo...
Read more
Las dos instituciones han firmado un convenio centrado en tres proyectos científicos sobre estrategias combinadas de inmunoterapia, moléculas para estimular el sistema inmune y terapias CAR-T
Read more
Researchers have joined forces to design using artificial intelligence and produce next-generation viral particles to be applied in advanced therapies. These particles can be used in immunotherapies, ...
Read more
The TRIP initiative establishes three new joint laboratories that bring together fundamental biomedical research and clinical research with the aim of accelerating the delivery of results to patients....
Read more
El convenio permite que las startups instaladas en LivingCells accedan de manera gratuita a los servicios de Madrid Impulsa Tech, entidad de enlace de la Innovación Tecnológica de la Comunidad de Ma...
Read more
Dos terapias CAR-T dirigidas a dos proteínas asociadas a tumores consiguen reducir el crecimiento tumoral en pacientes con glioblastoma.
Read more
These induced pluripotent stem cells (iPSCs) are created from adult cells from umbilical cord blood and can be used to produce advanced therapy drugs and test them in clinical trials, for example in r...
Read more
El resultado de un estudio pionero avala la seguridad de los bioimplantes llamados PeriCord, hechos de células madre de cordón umbilical y pericardio de un donante de tejidos que hace que la zona af...
Read more
Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium (CTS OpTmizer One SFM)*, a novel animal origin-free (AOF) formu...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
